Intrapleural Infusion of Activated Macrophages and γ-Interferon in Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

Intrapleural Infusion of Activated Macrophages and γ-Interferon in Malignant Pleural Mesothelioma

Published:2002-06 Issue:6 Volume:121 Page:1921-1927
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Monnet Isabelle,Breau Jean-Luc,Moro Denis,Lena Hervé,Eymard Jean-Christophe,Ménard Olivier,Vuillez Jean-Philippe,Chokri Mohamed,Romet-Lemonne Jean-Loup,Lopez Manuel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference39 articles.

1. The European mesothelioma epidemic;Peto;Br J Cancer,1999

2. Pleural mesothelioma: a descriptive analysis based on a case-control study and mortality data in Ile de France, 1987–1990;Iwatsubo;Am J Ind Med,1994

3. Diffuse malignant mesothelioma of the pleura in Ontario and Québec: a retrospective study of 332 patients;Ruffié;J Clin Oncol,1989

4. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B;Herndon;Chest,1998

5. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience;Curran;J Clin Oncol,1998

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?;Seminars in Respiratory and Critical Care Medicine;2023-06-12

2. Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies;Stem Cell Reports;2023-02

3. Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma;BMC Pulmonary Medicine;2021-05-05

4. Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms – Ein Experten-Konsensuspapier;Pneumologie;2021-05-04

5. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics;Vaccines;2021-01-27